Your session is about to expire
← Back to Search
Other
High Salt for Cardiovascular Risk
N/A
Waitlist Available
Led By Shannon L Lennon, PhD, RD
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up on day 10
Awards & highlights
Study Summary
This trial will study the effects of high dietary salt intake on gut microbiota composition in men and women.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ on day 10
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~on day 10
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Gut microbiota diversity
T cell profile
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: High SaltExperimental Treatment1 Intervention
Subjects will be counseled to consume a diet with 2,300 mg/d sodium which they will supplement with pills containing salt to achieve an intake of 6,900 mg/d sodium.
Group II: Recommended SaltPlacebo Group1 Intervention
Subjects will be counseled to consume a diet with 2,300 mg/d sodium which they will supplement with placebo pills.
Find a Location
Who is running the clinical trial?
University of DelawareLead Sponsor
154 Previous Clinical Trials
25,180 Total Patients Enrolled
7 Trials studying Cardiovascular Risk
367 Patients Enrolled for Cardiovascular Risk
Shannon L Lennon, PhD, RDPrincipal InvestigatorUniversity of Delaware
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger